Colorectal neoplasia differentially expressed (CRNDE) is an oncogenic long noncoding RNA (lncRNA). Increased CRNDE expression was initially discovered in colorectal cancer and then in a variety of solid tumors and hematological malignancies. CRNDE participates in multiple biological processes, such as cell proliferation, differentiation, migration, and apoptosis. CRNDE has been shown to modulate target gene expression through multiple mechanisms, including transcriptional regulation, post-transcriptional regulation, and competition for microRNA (miRNA) binding. In this review, we summarize the evidence that supports CRNDE in the diagnosis and prognosis predicting of cancers. The functional roles and molecular mechanisms of CRNDE are further described for major types of solid tumors and hematological malignancies. The therapeutic potential of CRNDE as a target for research and development is also discussed.
CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies
Xuefei Ma,W. Jin,Chaoxian Zhao,Xuefeng Wang,Kankan Wang
Published 2022 in Molecular Therapy: Nucleic Acids
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Molecular Therapy: Nucleic Acids
- Publication date
2022-03-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-91 of 91 references · Page 1 of 1
CITED BY
Showing 1-21 of 21 citing papers · Page 1 of 1